Effects of endothelin-1 eyedrops on the retina in rats

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Masuzawa, Koichi ^a   Miyauchi, Takashi ^a   Takanashi, Masakatsu ^a   Ogata, Takehiro ^a   Yamaguchi, Iwao ^a   Goto, Katsutoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin; Endothelin receptors; Eyedrops; Retina

Indexed keywords

ARTIFICIAL TEAR; ENDOTHELIN 1; EYE DROPS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINA DISEASE;

ADMINISTRATION, TOPICAL; ANIMALS; DOWN-REGULATION; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; MALE; OPHTHALMIC SOLUTIONS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RETINA; RETINAL DISEASES; RNA, MESSENGER;

EID: 11144338342     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166286.85785.a1     Document Type: Conference Paper

References (14)

1. Koevary SB, Nussey J, Lake S. Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats. Invest Ophthalmol Vis Sci. 2002;43:797-804.
2. Uchide T, Hiromi M, Mitsui Y, et al. Gene expression of vasoactive intestinal contractor/endothelin-2 in ovary, uterus, and embryo: comprehensive gene expression profiles of the endothelin ligand-receptor system revealed by semi-quantitative reverse transcriptionpolymerase chain reaction analysis in adult mouse tissues and during late embryonic development. J Mol Endocrinol. 1999;22:161-171.
3. De Juan JA, Moya FJ, Ripodas A, et al. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia. 2000;43:773-785.
4. Ripodas A, de Juan JA, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137-143.
5. Takagi C, Bursell SE, Lin YW, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci. 1996;37:2504-2518.
6. Takei K, Sato T, Nonoyama T, et al. A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits. Graefes Arch Clin Exp Ophthalmol. 1993;231:476-481.
7. Ota M, Oku H. Nicardipine modification of endothelin-1 effects on visual evoked potential. Jpn J Ophthalmol. 1997;41:38-42.
8. Ciulla TA, Pawlyk BS, Harris A, et al. Endothelin-1-mediated retinal artery vasospasm and the rabbit electroretinograrn. J Ocul Pharmacol Ther. 2000;16:393-398.
9. Mizuno K, Koide T, Yoshimura M, et al. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001;42:688-694.
10. 2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci. 2003;44:1169-1177.
11. Ahmed I, Patton TP. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985;26:584-587.
12. Riecke B, Chavakis E, Bretzel RG, et al. Topical application of integrin antagonists inhibits proliferative retinopathy. Horm Metab Res. 2001;33:307-311.
13. Koevary SB. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab. 2003;4:213-222.
14. Telemaque-Potts S, Kuc RE, Maguire JJ, et al. Elevated systemic levels of endothelin-1 and blood pressure correlate with blunted constrictor responses and downregulation of endothelin(A), but not endothelin(B), receptors in an animal model of hypertension. Clin Sci (Lond). 2002;103(suppl. 48):357S-362S.